Dubai – Mubasher: Hikma Pharmaceuticals Company posted on Wednesday a rise of 2% in 2015 revenues to $1.44 billion.
Operating profit also rose 4%, according to a bourse filing.
The company, listed in the London Stock Exchange and the NASDAQ stock market, expected its revenues to reach between $2 billion and $2.1 billion in 2016.
